DNase in stable cystic fibrosis infants: a pilot study

Slides:

Advertisements

Similar presentations

Long-term non-invasive ventilation in cystic fibrosis — Experience over two decades William G. Flight, Jonathan Shaw, Susan Johnson, A. Kevin Webb, Andrew.

Advertisements

Use of the insulin pump in treat cystic fibrosis related diabetes Dana S. Hardin, Julie Rice, Mark Rice, Randall Rosenblatt Journal of Cystic Fibrosis.

The effect of short-term, high-dose oral N-acetylcysteine treatment on oxidative stress markers in cystic fibrosis patients with chronic P. aeruginosa.

Cheryl Cameron, Mark W. Lodes, William M. Gershan

Poor growth in an infant with cystic fibrosis due to an antenatal perforation and incomplete bowel obstruction Isobel Brookes, Maya Desai, Gillian Duthie,

Ian D. Molyneux, Tanya Moon, A. Kevin Webb, Alyn H. Morice

Quoting a landmark paper on the beneficial effects of probiotics

Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation Kris De Boeck, Anne Munck, Seth Walker, Albert Faro,

Towards an individualized protocol for workload increments in cardiopulmonary exercise testing in children and adolescents with cystic fibrosis H.J.

Volume 137, Issue 6, Pages (December 2009)

Assessment of nutritional status in children with cystic fibrosis: conventional anthropometry and bioelectrical impedance analysis. A cross-sectional.

A. Mirakhur, M.J. Gallagher, M.J. Ledson, C.A. Hart, M.J. Walshaw

Scott D. Sagel, Marci K. Sontag, Meg M

Daily Observations of Nebuliser Use and Technique (DONUT) in children with cystic fibrosis Aukje C. Bos, Harm A.W.M. Tiddens, Kirby Tong Minh, Inge Heeres,

Oxidative stress in stable cystic fibrosis patients: Do we need higher antioxidant plasma levels? Antonela Lezo, Fiorella Biasi, Paola Massarenti, Roberto.

Megan R. Nelson, Craig R. Adamski, Audrey Tluczek

Successful treatment of cepacia syndrome

Amoxicillin–clavulanic acid resistance in fecal Enterobacteriaceae from patients with cystic fibrosis and healthy siblings Gwen Duytschaever, Geert Huys,

Urinary incontinence in 9��16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group W.J. Browne, C.J. Wood, M.

Nadav Traeger, Qiuhu Shi, Allen J. Dozor Journal of Cystic Fibrosis

Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation Kris De Boeck, Anne Munck, Seth Walker, Albert Faro,

Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of.

Family Caregiver Perspectives on Symptoms and Treatments for Patients Dying From Complications of Cystic Fibrosis Elisabeth P. Dellon, MD, MPH, Mitchell.

Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis T.W.V. Daniels, G.B. Rogers, F.A. Stressmann, C.J.

Controlled clinical trials in cystic fibrosis — are we doing better?

Corstiaan C. Breugem, Maruschka P. Merkus, J

D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams

Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox

José Luis Lezana, Mario H. Vargas, José Karam-Bechara, Ruth S

Gerd Döring, Patrick Flume, Harry Heijerman, J. Stuart Elborn

I Meyts, W Wuyts, M Proesmans, K De Boeck Journal of Cystic Fibrosis

The Journal of Cystic Fibrosis: Sunny perspectives

The predictive potential of the sweat chloride test in cystic fibrosis patients with the G551D mutation Verena I. Seliger, David Rodman, Fredrick Van.

Treatment response of airway clearance assessed by single-breath washout in children with cystic fibrosis Chiara Abbas, Florian Singer, Sophie Yammine,

Hypertonic saline and recombinant human DNase: a randomised cross-over pilot study in patients with cystic fibrosis Manfred Ballmann, Horst von der Hardt

Cytokines in nasal lavages and plasma and their correlation with clinical parameters in cystic fibrosis Marthe S. Paats, Ingrid M. Bergen, Marleen Bakker,

Aukje C. Bos, Kimberly M. Passé, Johan W. Mouton, Hettie M

A.H. Gifford Journal of Cystic Fibrosis

Treatment of resistant distal intestinal obstruction syndrome with a modified antegrade continence enema procedure I.J. Clifton, A.M. Morton, N.S. Ambrose,

Demographics of glucose metabolism in cystic fibrosis

Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor Meredith C. Fidler, Jack Beusmans, Paul Panorchan,

E. Tschiedel, H. Grasemann, F. Ratjen Journal of Cystic Fibrosis

Anastasios Lekkas, Khin M. Gyi, Margaret E. Hodson

Cardiac outcome in classic infantile Pompe disease after 13 years of treatment with recombinant human acid alpha-glucosidase Carine I. van Capelle, Esther.

Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis Geraint B. Rogers, Lucas R. Hoffman,

Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United.

Paternity in men with cystic fibrosis: a retrospective survey in France Ingrid Duguépéroux, Dominique Hubert, Stéphane Dominique, Gil Bellis, Marc De.

Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire Joän M. Patterson, Melanie Wall, Jerica.

Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa Karen O. McKay, Peter J. Cooper, Peter P. van.

Alina A. Ionescu, Lisette S. Nixon, Dennis J. Shale

Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005 F.A. Millar, N.J. Simmonds, M.E. Hodson Journal.

F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal

Peter J.F.M. Merkus, MD, PhD, H.A.W.M. Tiddens, MD CHEST

Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroids Francis J. Gilchrist, A.

D Peckham, A Watson, K Pollard, C Etherington, S.P Conway

Determining presence of lung disease in young children with cystic fibrosis: Lung clearance index, oxygen saturation and cough frequency E.M. Bakker,

Stability of interleukin 8 and neutrophil elastase in bronchoalveolar lavage fluid following long-term storage Luke J. Berry, Barbara Sheil, Luke Garratt,

H. White, A.M. Morton, S.P. Conway, D.G. Peckham

Osteoarthritis year 2012 in review: biology

Reviewer Acknowledgment

Sandra Voorend-van Bergen, MD, Anja A

Michael W. Konstan, David J. Pasta, Jeffrey S. Wagener, Donald R

‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis

Cheryl Cameron, Mark W. Lodes, William M. Gershan

David Adeboyeku, Sandra Scott, Margaret E. Hodson

Effects of creatine supplementation in cystic fibrosis: results of a pilot study Christian P. Braegger, Uwe Schlattner, Theo Wallimann, Anna Utiger, Friederike.

Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L

Does the timing of inhaled dornase alfa matter?

The acquisition of tolerance toward cow's milk through probiotic supplementation: A randomized, controlled trial Jeroen Hol, MD, Eduard H.G. van Leer,

Safety assessment of inhaled xylitol in subjects with cystic fibrosis

Presentation transcript:

DNase in stable cystic fibrosis infants: a pilot study Maartje ten Berge, Els van der Wiel, Harm A.W.M. Tiddens, Peter J.F.M. Merkus, Wim C.J. Hop, Johan C. de Jongste Journal of Cystic Fibrosis Volume 2, Issue 4, Pages 183-188 (December 2003) DOI: 10.1016/S1569-1993(03)00090-0

Fig. 1 Changes of V′maxFRC compared to baseline following treatment with RhDNase (8 paired measurements, left panel) or NaCl 0.9% (6 paired measurements, right panel). Treatment periods: 4 weeks, (open circles), or 2 weeks (open squares); *: P<0.002, paired t-test. (RhDNase compared to saline), left panel. Journal of Cystic Fibrosis 2003 2, 183-188DOI: (10.1016/S1569-1993(03)00090-0)

Fig. 2 Individual values of V′maxFRC during the study for group 1 (upper panel) and group 2 (lower panel). Journal of Cystic Fibrosis 2003 2, 183-188DOI: (10.1016/S1569-1993(03)00090-0)